Osaic Holdings
STRO icon

Osaic Holdings’s Sutro Biopharma STRO Stock Holding History

Osaic Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.9K Sell
1,280
-58
-4% -$1.05K ﹤0.01% 5538
2025
Q4 		$15.5K Sell
1,338
-777
-37% -$7.37K ﹤0.01% 6030
2025
Q3 		$18K Hold
2,115
– – ﹤0.01% 6003
2025
Q2 		$15K Sell
2,115
-185
-8% -$1.51K ﹤0.01% 5909
2025
Q1 		$14.9K Buy
2,300
+346
+18% +$5.45K ﹤0.01% 5558
2024
Q4 		$35.9K Buy
1,954
+899
+85% +$27.4K ﹤0.01% 4929
2024
Q3 		$36.5K Sell
1,055
-129
-11% -$5.06K ﹤0.01% 4961
2024
Q2 		$34.7K Buy
1,184
+99
+9% +$3.92K ﹤0.01% 4961
2024
Q1 		$61.3K Buy
1,085
+60
+6% +$2.65K ﹤0.01% 4596
2023
Q4 		$44K Hold
1,025
– – ﹤0.01% 4989
2023
Q3 		$35.6K Buy
1,025
+25
+3% +$1.09K ﹤0.01% 5219
2023
Q2 		$46.5K Hold
1,000
– – ﹤0.01% 4986
2023
Q1 		$46.2K Buy
1,000
+50
+5% +$3.17K ﹤0.01% 5011
2022
Q4 		$76.8K Buy
+950
New +$66K ﹤0.01% 4642
2021
Q1 		– Sell
-20
Closed -$4K – 6942
2020
Q4 		$4K Hold
20
– – ﹤0.01% 5880
2020
Q3 		$2K Hold
20
– – ﹤0.01% 5894
2020
Q2 		$2K Hold
20
– – ﹤0.01% 5829
2020
Q1 		$2K Buy
+20
New +$2.1K ﹤0.01% 5730

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Osaic Holdings's STRO Position: Q1 2026 in Review

Osaic Holdings reduced its Sutro Biopharma (STRO) stake by 4.3% in Q1 2026, selling an estimated $1.05K and leaving 1,280 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5538.

Osaic Holdings first reported a position in STRO in Q1 2020 and has held it in 18 quarters since. The position peaked at $76.8K in Q4 2022. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Osaic Holdings held 1,280 shares of Sutro Biopharma worth $31.9K as of Q1 2026.
  • Osaic Holdings sold 58 Sutro Biopharma shares in Q1 2026, an estimated $1.05K.
  • Sutro Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5538 holding.
  • Osaic Holdings first reported a position in Sutro Biopharma in Q1 2020 and has held it in 18 quarters since.
  • Osaic Holdings's Sutro Biopharma position peaked at $76.8K in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.